The Food and Drug Administration announced on November 4, 2026, that the shortage of Clonazepam Tablets has been resolved. The drug has been listed by the FDA since March 10, 2023.

Patients who rely on this medicine should talk to their pharmacist or doctor about alternatives. The FDA maintains the current list in its drug shortage database.

Press Release: Food and Drug Administration

Published November 4, 2026. Reproduced in full from the Food and Drug Administration.

Clonazepam Tablet shortage: Resolved

  • Drug: Clonazepam Tablet
  • Status: Resolved
  • Listed by FDA since: March 10, 2023
  • Last updated: November 4, 2026

Products and companies listed

  • Clonazepam, Tablet, 1 mg (NDC 59651-723-01): Aurobindo Pharma USA
  • Clonazepam, Tablet, 1 mg (NDC 0093-3212-01): Teva Pharmaceuticals USA, Inc.
  • Clonazepam, Tablet, 2 mg (NDC 72888-154-05): Rubicon Research Private Limited
  • Clonazepam, Tablet, 2 mg (NDC 16729-138-16): Accord Healthcare Inc.
  • Clonazepam, Tablet, 1 mg (NDC 0093-3212-05): Teva Pharmaceuticals USA, Inc.
  • Clonazepam, Tablet, .5 mg (NDC 72888-152-00): Rubicon Research Private Limited
  • Klonopin, Tablet, .5 mg (NDC 61269-605-10): Cheplapharm Arzneimittel GmbH
  • Clonazepam, Tablet, .5 mg (NDC 59651-722-99): Aurobindo Pharma USA
  • Clonazepam, Tablet, 1 mg (NDC 16729-137-00): Accord Healthcare Inc.
  • Clonazepam, Tablet, 1 mg (NDC 72888-153-00): Rubicon Research Private Limited
  • Clonazepam, Tablet, 2 mg (NDC 59651-724-01): Aurobindo Pharma USA
  • Clonazepam, Tablet, 1 mg (NDC 59651-723-99): Aurobindo Pharma USA

Patients who rely on this medicine should talk to their pharmacist or doctor about alternatives. FDA keeps the current list in its drug shortage database.